A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
A phase 1/2 trial of FOLFOX, Gemcitabine in metastatic cancer, run by Transcenta Therapeutics (Hangzhou) Co., Ltd., active and no longer recruiting.
Overview
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors is a phase 1/2 interventional study registered as NCT04396821 by Transcenta Therapeutics (Hangzhou) Co., Ltd., with 150 participants planned, started 2020-05-28 and due to reach its primary completion in 2026-05-30. Interventions recorded: TST001, Nivolumab Injection [Opdivo], mFOLFOX6, Gemcitabine, Albumin-Bound Paclitaxel. Conditions listed: Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Pancreatic Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
Shares TST001, Gemcitabine, Metastatic cancer (cancer that has spread).
- TrialSafety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
Shares Gemcitabine, Metastatic cancer (cancer that has spread).
- TrialA Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Shares Gemcitabine, Metastatic cancer (cancer that has spread).
- TrialStudy of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
Shares Gemcitabine, Metastatic cancer (cancer that has spread).
- TrialSpevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junct
- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Shares Gemcitabine, Metastatic cancer (cancer that has spread).
- TrialA Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Metastatic cancer (cancer that has spread).
- TrialA Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
Shares Gemcitabine, Metastatic cancer (cancer that has spread).